WASHINGTON, Dec. 21 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration issued a notice confirming that the injectable contraceptive Lunelle was not removed from the market because of safety or effectiveness problems. This decision allows the agency to approve generic versions of the drug for public use.

Lunelle, an injectable combination of estradiol cypionate and medroxyprogesterone acetate, received its initial approval in 2000 for the prevent . . .

Click here for more information about our products